Impact of Uncontrolled Symptoms on the Health-Related Quality of Life (EQ-5D-5L) of Patients With Allergic Rhinitis: A MASK-air Study

Rafael José Vieira^{1

2}, Lucas Leemann³, Holger J Schünemann^{4

5}, Luís Filipe Azevedo^{1

2}, João A Fonseca^{1

2}, Jean Bousquet^{6

7

8}, Bernardo Sousa-Pinto^{1

2}

Affiliations

¹ Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), Faculty of Medicine, University of Porto, Porto, Portugal.
² Centre for Health Technology and Services Research, Health Research Network (CINTESIS@RISE), Faculty of Medicine, University of Porto, Porto, Portugal.
³ Department of Political Science, University of Zurich, Zurich, Switzerland.
⁴ Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
⁵ Department of Biomedical Sciences, Humanitas University, Milan, Italy.
⁶ Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
⁷ Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
⁸ MASK-Air SAS, Montpellier, France.

Rafael José Vieira et al. Clin Exp Allergy. 2024 Aug.

. 2024 Aug;54(8):634-637.

doi: 10.1111/cea.14516. Epub 2024 Jun 20.

Rafael José Vieira^{1

2}, Lucas Leemann³, Holger J Schünemann^{4

5}, Luís Filipe Azevedo^{1

2}, João A Fonseca^{1

2}, Jean Bousquet^{6

7

8}, Bernardo Sousa-Pinto^{1

2}

¹ Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), Faculty of Medicine, University of Porto, Porto, Portugal.
² Centre for Health Technology and Services Research, Health Research Network (CINTESIS@RISE), Faculty of Medicine, University of Porto, Porto, Portugal.
³ Department of Political Science, University of Zurich, Zurich, Switzerland.
⁴ Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
⁵ Department of Biomedical Sciences, Humanitas University, Milan, Italy.
⁶ Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
⁷ Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
⁸ MASK-Air SAS, Montpellier, France.

No abstract available

Keywords: allergic rhinitis; asthma; mHealth; quality of life.

References

1. E. O. Meltzer, “Allergic Rhinitis: Burden of Illness, Quality of Life, Comorbidities, and Control,” Immunology and Allergy Clinics 36, no. 2 (2016): 235–248.
1. R. J. Vieira, L. Leemann, A. Briggs, et al., “Poor Rhinitis and Asthma Control is Associated With Decreased Health‐Related Quality‐of‐Life and Utilities: A MASK‐Air Study,” The Journal of Allergy and Clinical Immunology: In Practice 12 (2024): 1530–1538.e6, https://doi.org/10.1016/j.jaip.2024.03.036.
1. J. Bousquet, J. M. Anto, B. Sousa‐Pinto, et al., “Digitally‐Enabled, Patient‐Centred Care in Rhinitis and Asthma Multimorbidity: The ARIA‐MASK‐Air((R)) Approach,” Clinical and Translational Allergy 13, no. 1 (2023): e12215.
1. Digital Consent Around the World—Taylor Wessing's Global Data Hub. https://globaldatahub.taylorwessing.com/article/digital‐consent‐around‐t....
1. Y. S. Feng, T. Kohlmann, M. F. Janssen, and I. Buchholz, “Psychometric Properties of the EQ‐5D‐5L: A Systematic Review of the Literature,” Quality of Life Research 30, no. 3 (2021): 647–673.